Dean Diagnosis announced on October 19 that the third quarter of 2026 achieved operating income of 2,635 billion yuan, an increase of 0.23% year on year; net profit to mother of 250 million yuan, an increase of 438.03% year on year; and basic earnings per share of 0.4088 yuan. The first three quarters achieved operating income of 7.409 billion yuan, a year-on-year decrease of 2.07%; net profit to mother of 482 million yuan, an increase of 750.28%; and basic earnings per share of 0.789 yuan. During the reporting period, the company's revenue improved quarterly, and the operating recovery trend was steadily evident; deepened the strategic business layout and continued to increase the revenue share of high-value businesses; continued to expand high-value customers and further increased market share; comprehensively deepened refined management to promote a 1.35 percentage point year-on-year increase in comprehensive gross margin, and the profit structure and profit quality continued to be consolidated.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.